Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

ProFibrix expands management team

This article was originally published in Scrip

Executive Summary

ProFibrix, a Dutch biotech company focused on products to stop bleeding and initiate tissue repair, has appointed Dr Jan Ohrstrom chief operating officer and to its executive management team. He will be based in Seattle, US, where ProFibrix has established a wholly owned subsidiary – ProFibrix Inc. Dr Ohrstrom was previously part of the senior management team that took ZymoGenetics public.

Advertisement

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC030572

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel